---
figid: PMC5576374__12967_2017_1281_Fig1_HTML
figtitle: FLT3 kinase signaling pathway and sites blocked by FLT3 inhibitors
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC5576374
filename: 12967_2017_1281_Fig1_HTML.jpg
figlink: /pmc/articles/PMC5576374/figure/Fig1/
number: F1
caption: FLT3 kinase signaling pathway and sites blocked by FLT3 inhibitors. Sorafenib
  and quizartinib inhibit only FLT3窶的TD mutations, while midostaurin, crenolanib,
  and gilteritinib inhibit both FLT3窶的TD and FLT3 TKD mutations
papertitle: Molecular targeting in acute myeloid leukemia.
reftext: Seah H. Lim, et al. J Transl Med. 2017;15:183.
year: '2017'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9158089
figid_alias: PMC5576374__F1
figtype: Figure
redirect_from: /figures/PMC5576374__F1
ndex: bd22ce6c-def5-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5576374__12967_2017_1281_Fig1_HTML.html
  '@type': Dataset
  description: FLT3 kinase signaling pathway and sites blocked by FLT3 inhibitors.
    Sorafenib and quizartinib inhibit only FLT3窶的TD mutations, while midostaurin,
    crenolanib, and gilteritinib inhibit both FLT3窶的TD and FLT3 TKD mutations
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - AstC
  - tkd
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Src42A
  - Csk
  - Src64B
  - hop
  - bsk
  - ras
  - Ras64B
  - Ras85D
  - Raf
  - Akt
  - Stat92E
  - Dsor1
  - Mtk
  - Mtor
  - Tor
  - Erk7
  - rl
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - FLT1
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - SRC
  - FGR
  - FYN
  - YES1
  - JAK1
  - JAK2
  - JAK3
  - TYK2
  - KRAS
  - HRAS
  - NRAS
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - AKT1
  - AKT2
  - AKT3
  - SOAT1
  - STAT1
  - STAT2
  - STAT3
  - STAT4
  - STAT6
  - STAT5A
  - STAT5B
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - MTOR
  - EPHB2
  - MAPK1
  - MAPK3
  - Midostaurin
  - Quizartinib
  - Crenolanib
  - Tyrosine
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
---
